COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$427,908
+4.8%
64,933
+8.0%
0.00%0.0%
Q1 2023$408,249
+91027.0%
60,125
-0.7%
0.00%
-25.0%
Q4 2022$448
-99.9%
60,564
+17.5%
0.00%
-20.0%
Q3 2022$509,000
-9.3%
51,534
+0.1%
0.01%
-16.7%
Q2 2022$561,000
+3.3%
51,496
+7.2%
0.01%
+20.0%
Q1 2022$543,000
-17.9%
48,029
+14.1%
0.01%
-28.6%
Q4 2021$661,000
-8.6%
42,107
-0.2%
0.01%
-12.5%
Q3 2021$723,000
-21.2%
42,186
-1.1%
0.01%
-20.0%
Q2 2021$917,000
+44.2%
42,639
+0.7%
0.01%
+25.0%
Q1 2021$636,000
+14.2%
42,326
-0.1%
0.01%0.0%
Q4 2020$557,000
+35.9%
42,367
-0.1%
0.01%0.0%
Q3 2020$410,000
+31.4%
42,408
+55.3%
0.01%
+33.3%
Q2 2020$312,000
+12.2%
27,305
+1.8%
0.01%0.0%
Q1 2020$278,000
-6.4%
26,835
+48.4%
0.01%
+20.0%
Q4 2019$297,000
+23.8%
18,082
+0.1%
0.01%
+25.0%
Q3 2019$240,000
-6.2%
18,070
-0.4%
0.00%0.0%
Q2 2019$256,000
-22.9%
18,140
+0.4%
0.00%
-33.3%
Q1 2019$332,000
-29.4%
18,068
+0.5%
0.01%
-33.3%
Q4 2018$470,000
+63.8%
17,985
+43.8%
0.01%
+125.0%
Q3 2018$287,00012,5040.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders